173 related articles for article (PubMed ID: 30712302)
1. Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.
Crossin R; Scott D; Arunogiri S; Smith K; Dietze PM; Lubman DI
Med J Aust; 2019 Feb; 210(2):75-79. PubMed ID: 30712302
[TBL] [Abstract][Full Text] [Related]
2. Acute harms associated with inhalant misuse: Co-morbidities and trends relative to age and gender among ambulance attendees.
Crossin R; Scott D; Witt KG; Duncan JR; Smith K; Lubman DI
Drug Alcohol Depend; 2018 Sep; 190():46-53. PubMed ID: 29981942
[TBL] [Abstract][Full Text] [Related]
3. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
4. Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Heilbronn C; Lloyd B; McElwee P; Eade A; Lubman DI
Drug Alcohol Rev; 2013 Jul; 32(4):405-11. PubMed ID: 23350582
[TBL] [Abstract][Full Text] [Related]
5. Adolescent Suicidal Behaviors During the COVID-19 Pandemic in Australia: Analysis of Acute Harms Assessed via Ambulance Data.
Scott D; McGrath M; Beard N; Chislett S; Baldwin R; Nehme Z; Lubman DI; Ogeil RP
J Adolesc Health; 2024 May; 74(5):908-915. PubMed ID: 38340123
[TBL] [Abstract][Full Text] [Related]
6. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
Dietze PM; Cvetkovski S; Barratt MJ; Clemens S
Med J Aust; 2008 Jun; 188(12):709-11. PubMed ID: 18558893
[TBL] [Abstract][Full Text] [Related]
7. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018.
Nielsen S; Sanfilippo PG; Scott D; Lam T; Smith K; Lubman DI
Addiction; 2021 Aug; 116(8):2233-2241. PubMed ID: 33296537
[TBL] [Abstract][Full Text] [Related]
9. Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018.
Lam T; Kuhn L; Hayman J; Middleton M; Wilson J; Scott D; Lubman DI; Smith K; Nielsen S
Addiction; 2020 Feb; 115(2):261-269. PubMed ID: 31465131
[TBL] [Abstract][Full Text] [Related]
10. Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria.
Ogeil RP; Faulkner A; Beard N; Killian JJ; Arunogiri S; Phan V; Wilson J; Smith K; Lubman DI; Scott D
Int J Drug Policy; 2023 Jan; 111():103932. PubMed ID: 36527909
[TBL] [Abstract][Full Text] [Related]
11. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne.
Lloyd BK; McElwee PR
Drug Alcohol Rev; 2011 May; 30(3):271-80. PubMed ID: 21545557
[TBL] [Abstract][Full Text] [Related]
12. Self-reported sleep disturbance in ambulance attendances for suicidal ideation and attempted suicide between 2012 and 2017.
Ogeil RP; Witt K; Scott D; Smith K; Lubman DI
J Affect Disord; 2020 Mar; 265():364-371. PubMed ID: 32090761
[TBL] [Abstract][Full Text] [Related]
13. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
[TBL] [Abstract][Full Text] [Related]
14. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings.
Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA
Addiction; 2019 Jun; 114(6):1026-1034. PubMed ID: 30098227
[TBL] [Abstract][Full Text] [Related]
15. Opioid-related ambulance attendances during the first 2 years of the COVID-19 pandemic in Victoria, Australia.
McGrath M; Stare M; Chua P; Ogeil R; Nehme Z; Scott D; Lubman DI
Addiction; 2024 Feb; 119(2):348-355. PubMed ID: 37816493
[TBL] [Abstract][Full Text] [Related]
16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia.
Dietze P; Jolley D; Cvetkovski S; Cantwell K; Jacobs I; Indig D
Aust N Z J Public Health; 2004 Dec; 28(6):569-75. PubMed ID: 15707208
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study.
Abrahamsson T; Berge J; Öjehagen A; Håkansson A
Drug Alcohol Depend; 2017 May; 174():58-64. PubMed ID: 28315808
[TBL] [Abstract][Full Text] [Related]
19. The Incidence and Temporal Patterns of Use of Amphetamine-Type Stimulant Use in Traffic-Related Ambulance Attendances From 2015 to 2020 in Victoria, Australia.
Hayley AC; Ogeil RP; Faulkner A; Beard N; Downey LA; Smith K; Lubman DI; Scott D
J Stud Alcohol Drugs; 2023 Jan; 84(1):128-136. PubMed ID: 36799683
[TBL] [Abstract][Full Text] [Related]
20. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study.
Nielsen S; Crossin R; Middleton M; Martin C; Wilson J; Lam T; Scott D; Smith K; Lubman D
BMJ Open; 2019 May; 9(5):e029170. PubMed ID: 31138584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
